Nicotinamide Adenine Dinucleotide Responses to a Nutritional Supplement
The objective of this study is to evaluate nicotinamide adenine dinucleotide (NAD+) in response to a proprietary nutritional supplement in generally healthy adults, compared to placebo.
| Condition(s) | Healthy Adult |
|---|---|
| Status | Recruiting |
| Phase | NA |
| Study type | Interventional |
| Summary | The objective of this study is to evaluate nicotinamide adenine dinucleotide (NAD+) in response to a proprietary nutritional supplement in generally healthy adults, compared to placebo. |
| Who can participate | Inclusion Criteria: 1. Males and females, ≥45 to ≤65 years of age 2. BMI ≥18.5 and \<30.0 kg/m2 3. Ambulatory and currently free of injury or other physical impairment that hinders mobility. 4. Willing to use personal smart phone with operating system (Android version 12.0 or newer; iOS version 16 or newer). 5. Willingness to maintain current skin care regimen and avoid any skin-related medical procedures. 6. Willing to adhere to all study procedures, including lifestyle considerations and sign forms providing informed consent to participate in the study and authorization to release relevant protected health information to the Clinical Investigator. Exclusion Criteria: 1. Is currently following, or planning to be on, a weight loss regimen. 2. Weight loss or gain \>4.5 kg. 3. History of gas |
| Ages | 45 Years to 65 Years |
| Sex | All |
| Accepts healthy volunteers | Yes |
| Lead sponsor | Shaklee Corporation |
| Locations | Addison, Illinois, United States |
| Start date | 2026-02-17 |
| NCT ID | NCT07428889 |
| Official listing | https://clinicaltrials.gov/study/NCT07428889 |